Earlier cardiology trials were purely merit-driven, unlike the newer trials, which are industry-driven. Most of the trials from Europe, the United Kingdom, Sweden, Denmark, etc., are still funded by the state and are worth their weight in gold.
I look at some American trials skeptically, especially the device trills, where most primary investigators and collaborators have so much conflict of interest that you do not know where to begin or finish.
I'm sorry to say that. It results from practicing interventional cardiology in the United States and sitting in board rooms where you hear “Cash is King.”
“You eat what you kill.”
My claim to fame is that I have recruited patients for the 4S trial while practicing in Scotland!
So, I do appreciate the trials and trialists greatly 👍
Great summary.
I appreciate the effort.
Earlier cardiology trials were purely merit-driven, unlike the newer trials, which are industry-driven. Most of the trials from Europe, the United Kingdom, Sweden, Denmark, etc., are still funded by the state and are worth their weight in gold.
I look at some American trials skeptically, especially the device trills, where most primary investigators and collaborators have so much conflict of interest that you do not know where to begin or finish.
I'm sorry to say that. It results from practicing interventional cardiology in the United States and sitting in board rooms where you hear “Cash is King.”
“You eat what you kill.”
My claim to fame is that I have recruited patients for the 4S trial while practicing in Scotland!
So, I do appreciate the trials and trialists greatly 👍